Table 3.
Cell ID | Control
|
Gem
|
Bel
|
Gem + Bel
|
t-testa | ||||
---|---|---|---|---|---|---|---|---|---|
AVG | SD | AVG | SD | AVG | SD | AVG | SD | ||
WBCs (K/μL) | 5.6 | 2.4 | 3.3 | 0.8 | 4.9 | 1.3 | 2.3 | 1.1 | NS |
Neutrophills (K/μL) | 2.6 | 1.1 | 1.8 | 0.4 | 2.4 | 0.7 | 1.4 | 0.8 | NS |
Lymphocytes (K/μL) | 2.9 | 1.3 | 1.3 | 0.2 | 2.2 | 0.8 | 0.8 | 0.3 | NS |
Monocytes (K/μL) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | NS |
Eosinophils (K/μL) | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | NS |
Basophils (K/μL) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | NS |
RBCsb (M/μL) | 7.5 | 0.4 | 6.2 | 0.9 | 8.0 | 0.4 | 5.8 | 0.1 | * |
Hbc (g/dL) | 11.1 | 0.8 | 9.7 | 1.4 | 11.7 | 0.3 | 9.8 | 0.3 | ** |
Plateletsd (K/μL) | 723.0 | 314.1 | 590.0 | 37.0 | 861.0 | 69.2 | 1019.3 | 91.6 | * |
Gem, gemcitabine; Bel, belinostat; Gem + Bel, combination of gemcitabine and belinostat; AVG, average; SD, standard deviation.
t-test: significant difference by t-test; P-value (*, <0.05; **, <0.001); NS, not significant.
Bel > Gem + Bel*.
Bel > Gem + Bel**.
Gem < Gem + Bel*.